Rigel Pharmaceuticals RIGL reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:01 PM.
Here's what investors need to know about the announcement.
Rigel Pharmaceuticals missed estimated earnings by 14.29%, reporting an EPS of $-0.16 versus an estimate of $-0.14.
Revenue was down $64.28 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.02 which was followed by a 21.12% increase in the share price the next day.
Here's a look at Rigel Pharmaceuticals's past performance:
|Quarter||Q4 2021||Q3 2021||Q2 2021||Q1 2021|
To track all earnings releases for Rigel Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.